Format

Send to

Choose Destination
BMJ. 2016 Mar 14;352:i52. doi: 10.1136/bmj.i52.

Medical management of renal stones.

Author information

1
Department of Urology, UT Southwestern Medical Center, Dallas, TX 75390-9110, USA.
2
Department of Urology, UT Southwestern Medical Center, Dallas, TX 75390-9110, USA margaret.pearle@utsouthwestern.edu.

Abstract

The prevalence of kidney stones is increasing in industrialized nations, resulting in a corresponding rise in economic burden. Nephrolithiasis is now recognized as both a chronic and systemic condition, which further underscores the impact of the disease. Diet and environment play an important role in stone disease, presumably by modulating urine composition. Dietary modification as a preventive treatment to decrease lithogenic risk factors and prevent stone recurrence has gained interest because of its potential to be safer and more economical than drug treatment. However, not all abnormalities are likely to be amenable to dietary therapy, and in some cases drugs are necessary to reduce the risk of stone formation. Unfortunately, no new drugs have been developed for stone prevention since the 1980s when potassium citrate was introduced, perhaps because the long observation period needed to demonstrate efficacy discourages investigators from embarking on clinical trials. Nonetheless, effective established treatment regimens are currently available for stone prevention.

PMID:
26977089
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center